Quanterix Corporation (QTRX): Price and Financial Metrics
Quanterix Corporation (QTRX)
Today's Latest Price: $25.75 USD
Updated Jan 23 4:00pm
Add QTRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 55 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
QTRX Stock Summary
- Quanterix Corp's stock had its IPO on December 7, 2017, making it an older stock than only 5.47% of US equities in our set.
- QTRX's price/sales ratio is 11.73; that's higher than the P/S ratio of 89.86% of US stocks.
- As for revenue growth, note that QTRX's revenue has grown 55.03% over the past 12 months; that beats the revenue growth of 90.41% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Quanterix Corp, a group of peers worth examining would be IGC, DERM, LEAF, FLDM, and NEPT.
- Visit QTRX's SEC page to see the company's official filings. To visit the company's web site, go to www.quanterix.com.
QTRX Stock Price Chart More Charts
QTRX Price/Volume Stats
| Current price | $25.75 | 52-week high | $36.15 |
| Prev. close | $25.33 | 52-week low | $19.08 |
| Day low | $24.86 | Volume | 151,981 |
| Day high | $25.88 | Avg. volume | 156,485 |
| 50-day MA | $23.85 | Dividend yield | N/A |
| 200-day MA | $25.38 | Market Cap | 721.39M |
Quanterix Corporation (QTRX) Company Bio
Quanterix Corporation develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test. The company’s products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, assay development, and custom development services. Quanterix Corporation primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was founded in 2007 and is based in Lexington, Massachusetts.
Top Stories View All
Best & Worst Performing Stock Industries for January 23, 2020
Best & Worst Performing Small Cap Stocks for January 23, 2020
Best & Worst Performing Mid Cap Stocks for January 23, 2020
Best & Worst Performing Large Cap Stocks for January 23, 2020
Best & Worst Performing Mega Cap Stocks for January 23, 2020
View All Top Stories
Loading social stream, please wait...